Cost-effectiveness Analysis of GAAD algorithm on Hepatocellular Carcinoma Screening in Patients with Chronic Hepatitis B in China

Home / Key Publications / Health Economics / Cost-effectiveness Analysis of GAAD algorithm on Hepatocellular Carcinoma Screening in Patients with Chronic Hepatitis B in China

You May Also Like

Dr Ida talks about self-sampling

Expert Opinions: Thought Leadership for Healthcare Professionals

11 March 2026

Self-sampling in HPV Screening

12 February 2026

LEAD Perspective: Evaluating GAAD – A Malaysian Multicentre Study

12 February 2026

LEAD Perspective: The Taiwan Liver Story – Hepatitis Elimination and HCC Surveillance

SHARE

Be the first to receive updates, event opportunities, and thought leadership insights.